Organ preservation solution
This page covers all Organ preservation solution drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Reactive oxygen species (ROS), particularly hydroxyl radicals.
Targets
Reactive oxygen species (ROS), particularly hydroxyl radicals
Marketed (2)
- Custodiol Htk Soln · Lourdes Montero Cruces · Transplantation
Custodiol HTK is an organ preservation solution that maintains cellular viability during cold storage by providing essential electrolytes, buffers, and metabolic substrates while minimizing ischemic injury. - HTK Custodiol · Rigshospitalet, Denmark · Transplantation
HTK Custodiol is an organ preservation solution that maintains cellular viability during cold storage by providing essential electrolytes, buffers, and substrates while minimizing ischemic injury.
Phase 3 pipeline (3)
- Custodiol HTK · Marc Sakwa, MD · Transplantation
Custodiol HTK is an organ preservation solution that maintains cellular viability and reduces ischemic injury during organ transplantation by providing a balanced electrolyte composition and metabolic substrates. - Custodiol-N · Dr. F. Köhler Chemie GmbH · Transplantation
Custodiol-N is an organ preservation solution that maintains cellular viability and reduces ischemic injury during organ transplantation by providing essential electrolytes, substrates, and buffering capacity. - Hydrogen-Rich Celsior Solution · RenJi Hospital · Transplantation/Organ Preservation
Hydrogen-rich Celsior solution reduces ischemic reperfusion injury by providing antioxidant protection through molecular hydrogen during organ preservation and transplantation.